Page last updated: 2024-11-05

tranexamic acid and Laryngeal Neoplasms

tranexamic acid has been researched along with Laryngeal Neoplasms in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research Excerpts

ExcerptRelevanceReference
"None of the patients experienced further bleeding following the commencement of tranexamic acid treatment, and no adverse effect was noted."4.89Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review. ( Clark, JR; Elliott, M; Huang, J; Low, TH; Reid, C, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Low, TH1
Huang, J1
Reid, C1
Elliott, M1
Clark, JR1

Reviews

1 review available for tranexamic acid and Laryngeal Neoplasms

ArticleYear
Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review.
    The Laryngoscope, 2013, Volume: 123, Issue:10

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antifibrinolytic Agents; Carcinoma, Squamous Cell; Ep

2013